Companies Xtant Medical Holdings, Inc.
Xtant Medical (XTNT): executive pay, fiscal 2025
Free brief. Every figure links to the company’s own filing.
Email me Xtant Medical Holdings, Inc.’s executive pay brief as a PDF
It arrives in about 2 minutes, with every figure cited to its filing.
After the PDF, up to three short notes on the deeper reports for this company. Reply “unsubscribe” to any of them, any time.
CEO pay, last three years
- $2,461,736FY2024
- $1,351,676FY2025
CEO total pay was $1,351,676 in fiscal 2025, down from $2,461,736 in fiscal 2024.
FY2025: salary $624,000 · bonus $100,000 · stock awards $588,812 · option awards $0
Full detail
Every table from the filing. Open any section.
Summary compensation table
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Sean Browne | $624,000 | $100,000 | $588,812 | $0 | $0 | $0 | $38,864 | $1,351,676 |
| President and Chief Executive Officer | ||||||||
| Mark Schallenberger | 447,680 | 100,000 | 435,720 | 0 | 113,131 | 0 | 14,000 | 1,110,531 |
| Chief Operating Officer | ||||||||
| Scott Neils | 416,000 | 100,000 | 392,541 | 0 | 0 | 0 | 30,828 | 939,369 |
| Chief Financial Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
Three-year trend — total compensation per named executive
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Sean Browne | $1,351,676 | $2,461,736 | — | ↓ −1,110,060 |
| Mark Schallenberger | 1,110,531 | 878,961 | — | ↑ +231,570 |
| Scott Neils | 939,369 | 883,507 | — | ↑ +55,862 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
Incentive-plan design — the Compensation Discussion & Analysis
The executive compensation program is designed to provide a source of fixed income that is market competitive, motivate and reward executives for the achievement of annual corporate and individual objectives, and align the interests of executives with stockholders by encouraging a focus on long-term performance, promoting retention, and encouraging significant stock ownership.
| CEO STI target (% of salary) | — |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | — |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | true |
Equity grants and outstanding awards
No plan-based awards are on file for this fiscal year.
Outstanding equity awards at fiscal year-end 2025
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Scott Neils | RSU | 22,246 | — | $17,352 |
| Scott Neils | PSU | 26,329 | — | 20,537 |
| Mark Schallenberger | PSU | 29,225 | — | 22,796 |
| Sean Browne | PSU | 34,994 | — | 27,295 |
| Mark Schallenberger | RSU | 44,500 | — | 34,710 |
| Scott Neils | RSU | 58,072 | — | 45,296 |
| Mark Schallenberger | RSU | 58,072 | — | 45,296 |
| Scott Neils | RSU | 62,974 | — | 49,120 |
| Mark Schallenberger | PSU | 86,735 | — | 67,653 |
| Sean Browne | RSU | 87,108 | — | 67,944 |
| Scott Neils | PSU | 88,776 | — | 69,245 |
| Sean Browne | PSU | 365,816 | — | 285,336 |
Director compensation
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Stavros G. VizirgianakisIndependent · Board Chair · Nominating and Corporate Governance Committee (Chair) | $117,083 | $359,969 | $0 | — | $0 | $477,052 |
| Jonn R. BeesonIndependent · Audit Committee · Compensation Committee (Chair) | 82,865 | 102,848 | 0 | — | 0 | 185,713 |
| John K. BakewellIndependent · Audit Committee (Chair) · Nominating and Corporate Governance Committee | 82,500 | 102,848 | 0 | — | 0 | 185,348 |
| Tyler P. LipschultzIndependent · Audit Committee · Compensation Committee · Newly elected | 30,990 | 102,848 | 0 | — | 0 | 133,838 |
| Abhinav JainIndependent · Compensation Committee · Nominating and Corporate Governance Committee · Newly elected | 28,385 | 102,848 | 0 | — | 0 | 131,233 |
| Robert E. McNamaraIndependent · Not standing for re-election · Departed during FY | 48,125 | 0 | 0 | — | 0 | 48,125 |
| Lori D. Mitchell-KellerIndependent · Not standing for re-election · Departed during FY | 43,385 | 0 | 0 | — | 0 | 43,385 |
Board fee structure and ownership guideline
| Annual cash retainer | $55,000 |
|---|---|
| Annual equity retainer | $125,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 22,500 / 16,250 / 10,000 |
| Stock ownership guideline | — |
Total cost of the board
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $433,333 |
| Equity awards (grant-date value) | $771,361 |
| All other compensation | $0 |
| Total cost of the board | $1,204,694 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Peer group, and who names Xtant Medical as a peer
Companies that benchmark against XTNT
1 company names XTNT as a compensation peer
- MIMEDX GROUP, INC.MDXGFY2025
- SURMODICS INCSRDXFY2024
- SURMODICS INCSRMDFY2024
Each company listed discloses XTNT in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named XTNT in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
Chief executive pay against the peer group
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Xtant Medical Holdings, Inc. | 2025 | Sean Browne | $624,000 | $588,812 | $0 | $0 | $1,351,676 |
Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Say-on-pay history and pay ratio
No say-on-pay vote is on file for this company.
Insider trades since the proxy
No insider equity transactions reported since the proxy statement.
Sources (13 citations)
Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.
- Section 01, Sean Browne. DEF 14A, filed 2026-06-23. Section “Summary Compensation Table” · page 22. As printed: 1,351,676. View filing ↗
- Section 01, Mark Schallenberger. DEF 14A, filed 2026-06-23. Section “Summary Compensation Table” · page 22. As printed: 1,110,531. View filing ↗
- Section 01, Scott Neils. DEF 14A, filed 2026-06-23. Section “Summary Compensation Table” · page 22. As printed: 939,369. View filing ↗
- Section 08, Stavros G. Vizirgianakis. DEF 14A, filed 2026-06-23. Section “Director Compensation”. As printed: 477,052. View filing ↗
- Section 08, Jonn R. Beeson. DEF 14A, filed 2026-06-23. Section “Director Compensation”. As printed: 185,713. View filing ↗
- Section 08, John K. Bakewell. DEF 14A, filed 2026-06-23. Section “Director Compensation”. As printed: 185,348. View filing ↗
- Section 08, Tyler P. Lipschultz. DEF 14A, filed 2026-06-23. Section “Director Compensation”. As printed: 133,838. View filing ↗
- Section 08, Abhinav Jain. DEF 14A, filed 2026-06-23. Section “Director Compensation”. As printed: 131,233. View filing ↗
- Section 08, Robert E. McNamara. DEF 14A, filed 2026-06-23. Section “Director Compensation”. As printed: 48,125. View filing ↗
- Section 08, Lori D. Mitchell-Keller. DEF 14A, filed 2026-06-23. Section “Director Compensation”. As printed: 43,385. View filing ↗
- Section 01 trend, Δ column (computed). Computed. Δ = current-FY total − prior-FY total per named officer.
- Section 09b board cost (computed). Computed. Cash 433,333 + equity 771,361 + all other 0 = 1,204,694, summed across the director compensation table rows.
- Xtant Medical Holdings, Inc. (subject), Section 10b CEO total. DEF 14A, filed 2026-06-23. CEO total compensation as printed in Xtant Medical Holdings, Inc.'s own proxy. As printed: 1,351,676. View filing ↗